Evidence map›Paper›PMID 40625741›Full record

ReviewFrontiers in immunology2025

Thymic B cells in aging and autoimmune disease.

Sarah A Wedemeyer, Ann V Griffith

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sarah A WedemeyerDepartment of Microbiology, Immunology, & Molecular Genetics, UT Health San Antonio, San Antonio, TX, United States.
Ann V GriffithDepartment of Microbiology, Immunology, & Molecular Genetics, UT Health San Antonio, San Antonio, TX, United States.

Funding

South Texas Medical Scientist Training Program (STX-MSTP)T32GM145432 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jose E Cavazos, Ratna K Vadlamudi · 2023 to 2026
$2.3M
NIGMS NIH HHS T32 GM145432
6 · The paper itself

Abstract

Thymic B cells comprise a heterogenous population of cells localized primarily within the thymic medulla, a region populated by professional antigen-presenting cells (APCs) including dendritic cells, medullary thymic epithelial cells (mTECs), and macrophages. Through expression and presentation of self-antigens, these APCs are responsible for shaping the normal T cell repertoire by negatively selecting thymocytes recognizing self-antigens. It is now clear that thymic B cells have the capacity to participate in negative selection and present cognate antigens distinct from other medullary APCs, thus serving a non-redundant role in mediating T cell central tolerance. Recent work has linked thymic B cells with the development of multiple autoimmune diseases, many of which are increased in prevalence with aging. Here, we will provide a brief overview of the role of thymic B cell subsets in promoting negative selection and immune homeostasis, with a primary focus on the impact of aging on their tolerizing capacity and involvement in autoimmune diseases, highlighting thymic B cells as a potential novel therapeutic target to improve clinical outcomes in patients with autoimmune diseases.

Indexed as

AgingAutoimmune DiseasesB-LymphocytesThymus GlandAnimalsHumansImmune Toleranceagingautoimmune diseaseB cellsthymustolerance

Identifiers

PMID40625741
PMCPMC12230088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.